Curbing Drug Evergreening Using Competition Law
- IJLLR Journal
- 10h
- 1 min read
Gladys Geethanjali S, VIT School of Chennai
ABSTRACT
The concept of evergreening of patents is adopted by the pharmaceutical industry to extend patent protection through minor modifications of existing drugs. This has caused significant debate regarding the impact on market competition and consumer access to affordable drugs. This paper examines the interface between competition law and patent laws, in order to understand how practices that lead to monopolistic dominance, possibly stifling innovation and delaying the entry of generic alternatives, can be mitigated hand-in-hand. Furthermore, it explores the legal frameworks and judicial doctrines in the jurisdiction of the United States, European Union and India. It seeks to find the effectiveness of the current competition laws in addressing patent manipulation to balance the protection of genuine pharmaceutical innovations and public welfare.